Document:

-----------------------
Name of Offeree

                                SPO MEDICAL INC.
                             SUBSCRIPTION AGREEMENT

SPO Medical  Inc.
21860 Burbank Blvd, Suite 380,
Woodland Hills,
California 91367

Attention:  Michael Braunold

Gentlemen:

1.       Subscription. (a) Subject to the terms and conditions of this Agreement
the undersigned hereby agrees to loan to SPO Medical Inc., a Delaware
corporation (the "Company"), the principal amount set forth on the Purchaser's
signature page of this Agreement (the "Purchase Price"), out of the aggregate
amount being loaned by all Purchasers of a minimum of US $350,000 and maximum of
US $500,000 (the "Offering"). The Company may increase the aggregate amount of
the Offering by $50,000.

         (b) The obligation to repay the loan from the Purchaser shall be
evidenced by the Company's issuance of one or more 8% promissory notes with
interest and principal repayable at the end of 12 months ("Note"). In addition
the Company shall issue to each Purchaser a two year common stock purchase
warrant to purchase 16,250 shares of Common Stock of the Company for each
$25,000 of principal loaned to Company exercisable at the lower of $1.50 per
share or 35% less than any IPO of Company stock during the Warrant exercise
period (the "Warrant"). The terms of the Note and Warrant (jointly the
"Unit(s)") are set forth in Exhibit "A" and "B" to this Agreement.

         (c) The Purchaser understands that this subscription may be rejected by
the Company at any time in its sole discretion and that the Company will advise
the Purchaser as soon as practicable if the Purchaser's subscription has not
been accepted. If rejected, all amounts delivered by the Purchaser as payment
for the Units will be promptly returned to the Purchaser and this Agreement
shall have no further force or effect (except for the provisions of Section 14
hereof). If the Purchaser's subscription is rejected, the Purchaser agrees to
return to the Company any documents the Company has provided to the Purchaser
for the purpose of evaluating its investment in the Units. If the Purchaser's
subscription is accepted, the Company will promptly provide the Purchaser with a
Note and Warrant that constitute the Units purchased.

<PAGE>

2.       Payment. Upon execution of this Agreement, the Purchaser will pay by
bank check or wire transfer the full amount of the purchase price of the Units
for which the Purchaser is subscribing pursuant to the terms of this Agreement.
Money shall be sent to the escrow agent as follows. If by wire:

Bank of America
Address: 260 Canal Street
New York, New York
Account #: 2163015671
ABA #: 021200339
Swift Code: FNBBUS33
Account Beneficiary: Lawrence Katz
Reference: SPO Medical Inc.

Or by check to: Lawrence Katz as Attorney

Or wired directly to the Company.

3.       Representations, Warranties and Covenants of the Purchaser. The
Purchaser hereby acknowledges that his investment in the Units involves a high
degree of risk and his economic circumstances are such that he can afford the
loss of his investment. The Purchaser further acknowledges, represents, warrants
and agrees as follows:

         (a) The Purchaser is an "accredited investor" as defined by Rule 501
under the Securities Act of 1933, as amended (the "Act"), and the Purchaser is
capable of evaluating the merits and risks of Subscriber's investment in the
Company and has the capacity to protect the Purchaser's own interests. The
Purchaser meets the requirements of at least one of the suitability standards
for an "accredited investor" as set forth on the Accredited Investor
Certification contained herein;

         (b) None of the Units have been registered under the Act or any state
securities laws. The Purchaser understands that the offering and sale of the
Units is intended to be exempt from registration under the Act, by virtue of
Section 4(2) and/or Section 4(6) thereof and the provisions of Regulation D
promulgated thereunder, based, in part, upon the representations, warranties and
agreements of the Purchaser contained in this Agreement;

         (c) Neither the Securities and Exchange Commission nor any state
securities commission has approved the sale of the Units or the common stock
being purchased hereby or into which the warrants are convertible nor has the
Commission passed upon or endorsed the merits of the Offering;

                                       2
<PAGE>

         (d) The Purchaser has had the opportunity to obtain any information, to
the extent the Company had such information in its possession or could acquire
it without unreasonable effort or expense, necessary to verify the accuracy of
the information contained in all documents received or reviewed in connection
with the purchase of the Units and has had the opportunity to meet with
representatives of the Company and to have them answer any questions and provide
such additional information regarding the terms and conditions of this
particular investment and the finances, operations, business and prospects of
the Company deemed relevant by the Purchaser.

         (e) In evaluating the suitability of an investment in the Company, the
Purchaser has not relied upon any representation or other information (oral or
written) other than as contained in documents so furnished to the Purchaser by
the Company. The Purchaser and its advisors, if any, have been furnished with or
have been given access to all materials relating to the business, finances and
operations of the Company and materials relating to the offer and sale of the
Units which have been requested by the Purchaser, including those set forth on
in any annex attached hereto. The Purchaser and its advisors, if any, have been
afforded the opportunity to ask questions of the Company and its management and
have received complete and satisfactory answers to any such inquiries;

         (f) The Purchaser is unaware of, is in no way relying on, and did not
become aware of the Offering of the Units through or as a result of, any form of
general solicitation or general advertising including, without limitation, any
article, notice, advertisement or other communications published in any
newspaper, magazine or similar media or broadcast over television or radio, in
connection with the Offering and is not subscribing for Units and did not become
aware of the Offering as a result of any seminar or meeting to which the
Purchaser was invited by, or any solicitation of a subscription by, a person not
previously known to the Purchaser;

         (g) The Purchaser has taken no action which would give rise to any
claim by any person for brokerage commissions, finders' fees or the like
relating to this Agreement or the transactions contemplated hereby;

         (h) The Purchaser has sufficient knowledge and experience in financial,
tax, and business matters, and, in particular, investments in securities, so as
to enable the Purchaser to utilize the information made available to the
Purchaser to evaluate the merits and risks of an investment in the Units and to
make an informed investment decision with respect thereto;

         (i) The Purchaser is acquiring the Units solely for his own account for
investment and not with a view to resale or distribution thereof, in whole or in
part. The Purchaser has no agreement or arrangement, formal or informal, with
any person to sell or transfer all or any part of the Units purchased hereunder,
and the Purchaser has no plans to enter into any such agreement or arrangement;

                                       3
<PAGE>

         (j) The Purchaser must bear the substantial economic risks of the
investment in the Units indefinitely because none of the securities included in
the Units may be sold, hypothecated or otherwise disposed of unless subsequently
registered under the Act and applicable state securities laws or an exemption
from such registration is available. The Purchaser acknowledges and understands
legends shall be placed on the certificates representing the shares of common
stock into which the warrants are convertible to the effect that they have not
been registered under the Act or applicable state securities laws. Appropriate
notations thereof will be made on the securities issued substantially as
follows:

         "THE SECURITIES EVIDENCED HEREBY HAVE NOT BEEN REGISTERED UNDER THE
         SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), AND MAY NOT BE
         TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION UNDER THE ACT
         OR IN A TRANSACTION WHICH, IN THE OPINION OF COUNSEL REASONABLY
         SATISFACTORY TO THE COMPANY, QUALIFIES AS AN EXEMPT TRANSACTION UNDER
         THE ACT AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER."

         (k) In addition, the certificates representing the common stock of the
Company, and any and all securities issued in replacement thereof or in exchange
therefore, shall bear such legend as may be required by the securities laws of
the jurisdiction in which Purchaser resides.

         (l) The Purchaser has adequate means of providing for the purchaser's
current financial needs and foreseeable contingencies and has no need for
liquidity of the investment in the Units for an indefinite period of time;

         (m) The Purchaser: (i) if a natural person represents that he has
reached the age of 21 and has full power and authority to execute and deliver
this Agreement and all other related agreements or certificates and to carry out
the provisions hereof and thereof and has adequate means for providing for his
current financial needs and anticipated future needs and possible personal
contingencies and emergencies and has no need for liquidity in the investment in
the Units; (ii) if a corporation, partnership, limited liability company or
partnership, association, joint stock company, trust, unincorporated
organization or other entity represents that such entity is duly organized,
validly existing and in good standing under the laws of the state of its
organization, the consummation of the transactions contemplated hereby is
authorized by, and will not result in a violation of state law or its charter or
other organizational documents, such entity has full power and authority to
execute and deliver this Agreement and all other related agreements or
certificates and to carry out the provisions hereof and thereof and to purchase
and hold the securities constituting the Units, the execution and delivery of
this Agreement has been duly authorized by all necessary action, this Agreement
has been duly executed and delivered on behalf of such entity and is a legal,
valid and binding obligation of such entity; and (iii) if executing this
Agreement in a representative or fiduciary capacity, represents that it has full
power and authority to execute and deliver this Agreement in such capacity and
on behalf of the subscribing individual, ward, partnership, trust, estate,
corporation, limited liability company or partnership, or other entity has full
right and power to perform pursuant to this Agreement and make an investment in
the Company, and that this Agreement constitutes a legal, valid and binding
obligation of such entity. The execution and delivery of this Agreement will not
violate or be in conflict with any order, judgment, injunction, agreement or
controlling document to which the Purchaser is a party or by which it is bound;

                                       4
<PAGE>

         (n) Any information which the Purchaser has heretofore furnished or
furnishes herewith to the Company is complete and accurate and may be relied
upon by the Company in determining the availability of an exemption from
registration under federal and state securities laws in connection with the
offering of the Units. The Purchaser further represents, warrants and covenants
that it will notify and supply corrective information to the Company immediately
upon the occurrence of any change therein occurring prior to the Company's
issuance of the Units;

         (o) The Purchaser acknowledges that the Company is in the development
stage, has been engaged in business for only a short period of time and has
limited operations. The Purchaser is knowledgeable about investment
considerations in development-stage companies. The Purchaser's overall
commitment to investments which are not readily marketable is not excessive in
view of the Purchaser's net worth and financial circumstances and the purchase
of the Units will not cause such commitment to become excessive. The investment
in the Units is suitable one for the Purchaser;

         (p) Within three days after receipt of a request from the Company, the
Purchaser will provide such information and deliver such documents as may
reasonably be necessary to comply with any and all laws and ordinances to which
the Company or the selected dealers is subject; and

         (q) The Purchaser agrees that it may not sell, transfer, pledge,
encumber, hypothecate, permit to be subject to a security interest, grant an
option in or otherwise dispose of the Units being acquired hereunder or the
shares of Common Stock into which the warrants are to be convertible unless such
securities are registered under the Securities Act or unless an opinion of
counsel satisfactory is delivered to the Company that no such registration is
required is delivered to the Company;

4.       Representations and Warranties of the Company. The Company represents
and warrants to the Purchaser as follows:

         4.1 Organization and Authority; Subsidiaries. The Company is a
corporation validly existing and in good standing under the laws of the State of
Delaware, with full power and authority to enter into and perform this Agreement
and the other agreements contemplated hereby to which it is a party. The Company
is duly licensed or qualified to do business as a foreign corporation and is in
good standing under the laws of all other jurisdictions in which the character
of the properties owned or leased by it therein or in which the transaction of
its business makes such qualification necessary, except for jurisdictions where
failure to become licensed or to so qualify could not reasonably be expected to
have a material adverse effect on the business and operations of the Company
taken as a whole. The Company has all requisite corporate power and authority to
own its properties, to carry on its business as now conducted, and to enter into
and perform its obligations under this Agreement.

                                       5
<PAGE>

      4.2 Authorization; Binding Effect. The Company has taken all corporate
actions which are necessary to authorize the execution, delivery and performance
of this Agreement and the consummation of the transactions contemplated hereby.

      4.3 No Bankruptcy or Insolvency. The Company has not filed any voluntary
petition in bankruptcy or been adjudicated a bankrupt or insolvent, filed by
petition or answer seeking any reorganization, liquidation, dissolution or
similar relief under any federal bankruptcy, insolvency, or other debtor relief
law, or sought or consented to or acquiesced in the appointment of any trustee,
receiver, conservator or liquidator of all or any substantial part of its
properties. No court of competent jurisdiction has entered an order, judgment or
decree approving a petition filed against the Company seeking any
reorganization, arrangement, composition, readjustment, liquidation, dissolution
or similar relief under any federal bankruptcy act, or other debtor relief law,
and no other liquidator has been appointed of the Company or of all or any
substantial part of its properties.

      4.4 No Litigation. There are no actions, suits or proceedings of any type
pending or, to the knowledge of the Company, threatened, against the Company
which if adversely determined could have a material adverse effect on the
business and operations of the Company taken as a whole.

      4.5 Investment Company. The Company is not, and is not controlled by, an
"Investment Company" within the meaning of the Investment Company Act.

      4.6 Governmental Consents and Notices. No consent, approval or
authorization of or designation, declaration or filing with any governmental
authority on the part of the Company is required in connection with the valid
execution and delivery of this Agreement, or the offer, sale or issuance of the
Units, or the consummation of any other transaction contemplated hereby, except
qualification (or taking such action as may be necessary to secure an exemption
from qualification, if available) of the offer and sale of the Units under
applicable state and federal securities laws, which qualification if required,
will be accomplished in a timely manner.

      4.7 Finders/Placement Agents. The Company may retain the services of a
placement agent(s) who may receive a due diligence fee of up to $20,000 plus 5%
warrant coverage. Such warrants issued to placement agent shall be in the form
of the Warrant.

                                       6
<PAGE>

      4.8 Units and Common Stock. The Units and Common Stock, into which the
warrants are convertible, when issued, will be duly authorized, validly issued,
fully paid and nonassessable.

      4.9 Ownership. The Company, through its wholly-owned subsidiary, is the
sole and exclusive owner of the patents referenced in the business plan of the
Company, and that the same have not been hypothecated or otherwise encumbered by
the Company.

      4.10 Intellectual Property Rights and Interests. The Company has not
received any written or oral notice or claim that the Company is infringing the
intellectual property rights of any other person or legal entity or that the
Company is in material breach or default of any license granting to the Company
rights in any intellectual property. To the knowledge of the Company as of the
date hereof, without having conducted any independent investigation or analysis
of its intellectual property rights and the use thereof by third parties, no
third party is infringing upon any intellectual property rights proprietary to
the Company.

5.    Indemnification. (a) The Purchaser agrees to indemnify and hold harmless
the Company, and its officers, directors, employees, agents, control persons and
affiliates against all losses, liabilities, claims, damages, and expenses
whatsoever (including, but not limited to, any and all expenses incurred in
investigating, preparing, or defending against any litigation commenced or
threatened) based upon or arising out of any actual or alleged false
representation or warranty, or misrepresentation or omission to state a material
fact, or breach by the Purchaser of any covenant or agreement made by the
Purchaser herein or in any other document delivered in connection with this
Agreement.

      (b) The Company agrees to indemnify and hold harmless the Purchaser, and
its officers, directors, employees, agents, control persons and affiliates
against all losses, liabilities, claims, damages, and expenses whatsoever
(including, but not limited to, any and all expenses incurred in investigating,
preparing, or defending against any litigation commenced or threatened) based
upon or arising out of any actual or alleged false representation or warranty,
or misrepresentation or omission to state a material fact, or breach by the
Company of any covenant or agreement made by the Company herein or in any other
document delivered in connection with this Agreement.

6.    Registration Rights. In consideration of the purchase of the Units by the
Purchaser described in this Agreement, the Company will register the shares of
common stock underlying the Warrants ("Stock") by filing a registration
statement within 180 days from the final closing of the Offering with respect to
the resale by the Purchaser of the shares of Common Stock issuable upon exercise
of the Warrant; provided, however, if within 180 days from the final closing of
the Offering the Company effects a public offering of its securities or lists
its securities on a stock exchange and the Purchaser is thereafter entitled
under law to sale its Stock without a registration statement on such stock
exchange (the "Exempt IPO"), the Purchaser hereby waives its rights under this
Section 6. The Purchaser's rights hereunder shall be subject to its compliance
with the conditions or restrictions, including without limitation, lock-ups,
required by an underwriter (in the case of an underwritten offering of Shares).

                                       7
<PAGE>

7.    Deleted

8.    Irrevocability; Binding Effect. The Purchaser hereby acknowledges and
agrees that the subscription hereunder is irrevocable by the Purchaser, except
as required by applicable law, and that this Agreement shall survive the death
or disability of the Purchaser and shall be binding upon and inure to the
benefit of the parties and their heirs, executors, administrators, successors,
legal representatives, and permitted assigns. If the Purchaser is more than one
person, the obligations of the Purchaser hereunder shall be joint and several
and the agreements, representations, warranties, and acknowledgments herein
shall be deemed to be made by and be binding upon each such person and such
person's heirs, executors, administrators, successors, legal representatives,
and permitted assigns.

9.    Amendment. This Agreement shall not be amended, modified or waived except
by an instrument in writing signed by the party against whom any such amendment,
modification or waiver is sought.

10.   Notices. Any notice or other communication required or permitted to be
given hereunder shall be in writing

(a) if to Company, at the address set forth above,

with a copy to:

                           Aboudi & Brounstein
                           Law Offices
                           Rechov Gavish 3, POB 2432
                           Kfar Saba Industrial Zone 44641 Israel
                           Telephone No.: (011-972-9) 764-4833
                           Telecopier No.: (011-972-9) 764-4834
                           David@a-blaw.com

(b) if to the Purchaser,
at the address set forth on the signature page hereof with a copy of all such
communications being sent to the escrow agent,

11.   Assignability. This Agreement and the rights, interests and obligations
hereunder are not transferable or assignable by the Purchaser.

12.   Applicable Law. This Agreement shall be governed by and construed in
accordance with the laws of the State of New York without regard to its
conflicts of laws principles. The Purchaser hereby irrevocably submits to the
jurisdiction of any United States district court located in the City of New York
over any action or proceeding arising out of or relating to this Agreement. The
Purchaser further agrees that any action or proceeding brought against the
Company shall be brought only in the United States district courts located in
the City of New York.

                                       8
<PAGE>

13.   Use of Pronouns. All pronouns and any variations thereof used herein shall
be deemed to refer to the masculine, feminine, neuter, singular or plural as the
identity of the person or persons referred to may require.

14.   Confidentiality. The Purchaser acknowledges and agrees that any
information or data it has obtained from or about the Company, including,
without limitation, the business plan of the Company, not otherwise properly in
the public domain, was received in confidence. The Purchaser agrees not to
divulge, communicate or disclose, except as may be required by law or for the
performance of this Agreement, or use to the detriment of the Company or for the
benefit of any other person or persons, or misuse in any way, any confidential
information of the Company, including any scientific, technical, trade or
business secrets of the Company and any scientific, technical, trade or business
materials that are treated by the Company as confidential or proprietary,
including, but not limited to, ideas, discoveries, inventions, developments and
improvements belonging to the Company and confidential information obtained by
or given to the Company about or belonging to third parties.

15.   Miscellaneous.

      (a)   This Agreement constitutes the entire agreement between the
            Purchaser and the Company with respect to the subject matter hereof
            and supersede all prior oral or written agreements and
            understandings, if any, relating to the subject matter hereof. The
            terms and provisions of this Agreement may be waived, or consent for
            the departure therefrom granted, only by a written document executed
            by the party entitled to the benefits of such terms or provisions.

      (b)   The Purchaser's representations and warranties made in this
            Agreement shall survive the execution and delivery hereof and
            delivery of the Units to the Purchaser.

      (c)   Each of the parties hereto shall pay its own fees and expenses
            (including the fees of any attorneys, accountants, appraisers or
            others engaged by such party) in connection with this Agreement and
            the transactions contemplated hereby whether or not the transactions
            contemplated hereby are consummated.

                                       9
<PAGE>

      (d)   This Agreement may be executed in one or more counterparts each of
            which shall be deemed an original, but all of which shall together
            constitute one and the same instrument.

      (e)   Each provision of this Agreement shall be considered separable and
            if for any reason any provision or provisions hereof are determined
            to be invalid or contrary to applicable law, such invalidity or
            illegality shall not impair the operation of or affect the remaining
            portions of this Agreement.

      (f)   Paragraph titles are for descriptive purposes only and shall not
            control or alter the meaning of this Agreement as set forth in the
            text.

               Accredited Investor Certification and Questionnaire
               ---------------------------------------------------
                         (Check the appropriate box(es))

1.    Please check the appropriate box.

____  (i) I am a natural person who had individual income of more than
      $200,000 in each of the most recent two years or joint income with my
      spouse in excess of $300,000 in each of the most recent two years and
      reasonably expect to reach that same income level for the current year
      ("income", for purposes hereof, should be computed as follows:
      individual adjusted gross income, as reported (or to be reported) on a
      federal income tax return, increased by (1) any deduction of long-term
      capital gains under Section 1202 of the Internal Revenue Code of 1986
      (the "Code"), (2) any deduction for depletion under Section 611 et seq.
      of the Code, (3) any exclusion for interest under Section 103 of the
      Code and (4) any losses of a partnership as reported on Schedule E of
      From 1040);

____  (ii) I am a natural person whose individual net worth (i.e., total
      assets in excess of total liabilities), or joint net worth with my
      spouse, will at the time of purchase of the Units described in this
      subscription agreement to which this certification is attached be in
      excess of $1,000,000;

____  (iii) The Purchaser is an investor satisfying the requirements of
      Section 501(a)(1), (2) or (3) of Regulation D promulgated under the
      Securities Act, which includes but is not limited to, a self-directed
      employee benefit plan where investment decisions are made solely by
      persons who are "accredited investors" as otherwise defined in
      Regulation D;

                                       10
<PAGE>

____  (iv) The Purchaser is a trust, which trust has total assets in excess
      of $5,000,000, which is not formed for the specific purpose of
      acquiring the Units offered hereby and whose purchase is directed by a
      sophisticated person as described in Rule 506(b)(ii) of Regulation D
      and who has such knowledge and experience in financial and business
      matters that he is capable of evaluating the risks and merits of an
      investment in the Units;

____  (v)  I am a director or executive officer of the Company; or

____  (vi) The  Purchaser is an entity  (other than a trust) in which all of the
      equity  owners meet the requirements of at least one of the above
      subparagraphs.

      The undersigned agrees that the undersigned will notify the Company at
any time on or prior to the Closing in the event that the representations and
warranties in this Accredited Investor Certification and Questionnaire shall
cease to be true, accurate and complete.

(2)   Suitability (please answer each question)

      a)    For an individual, please describe any college or graduate degrees
            held by you:

      b)    For all subscribers, please state whether you have you participated
            in other private placements before:

                           YES                     NO
                                  ----------                 ---------

      (c)   If your answer to question (b) above was "YES", please indicate
            frequency of such prior participation in private placements of:

                                          Public           Private
                                          Companies        Companies
                                          ______________   _______________

                           Frequently     ______________   _______________
                           Occasionally   ______________   _______________
                           Never          ______________   _______________

      (d)   For individuals, do you expect your current level of income to
            significantly decrease in the foreseeable future?

                           YES                     NO
                                  ----------                 ---------

      (e)   For trust, corporate, partnership and other institutional
            subscribers, do you expect your total assets to significantly
            decrease in the foreseeable future?

                           YES                     NO
                                  ----------                 ---------

                                       11
<PAGE>

      (f)   For all subscribers, are you familiar with the risk aspects and the
            non-liquidity of investments such as the Securities for which you
            seek to purchase?

                           YES                     NO
                                  ----------                 ---------

      (g)   For all subscribers, do you understand that there is no guarantee of
            financial return on this investment and that you run the risk of
            losing your entire investment?

                           YES                     NO
                                  ----------                 ---------

      (3)   Manner in which title is to be held: (circle one)

                  (a)      Individual Ownership
                  (b)      Community Property
                  (c)      Joint Tenant with Right of Survivorship (both parties
                           must sign)
                  (d)      Partnership
                  (e)      Tenants in Common
                  (f)      Company
                  (g)      Trust
                  (h)      Other

      (4)   NASD Affiliation.

                  Are you affiliated or associated with an NASD member firm
                  (please check one):

                           YES                     NO
                                  ----------                 ---------

                  If Yes, please describe:

                  _____________________________________________________________
                  _____________________________________________________________
                  _____________________________________________________________

                  *If subscriber is a Registered Representative with an NASD
                  member firm, have the following acknowledgment signed by the
                  appropriate party:

                  The undersigned NASD member firm acknowledges receipt of the
                  notice required by the NASD Conduct Rules.

                                       12
<PAGE>

                  __________________________________
                  Name of NASD Member Firm

                  By: ______________________________
                           Authorized Officer

                  Date: ____________________________

         The undersigned is informed of the significance to the Company of the
foregoing representations and answers contained in this Purchaser Questionnaire
and such answers have been provided under the assumption that the Company will
rely on them.

         [Remainder of page intentionally blank, signature pages follow]

                                       13

<PAGE>

         IN WITNESS WHEREOF, the Purchaser has executed this Agreement this ____
day of ____________ , 2006.

__________________________
(Loan - Purchase Price)

If the Purchaser is an INDIVIDUAL, or if purchased as JOINT TENANTS, as TENANTS
IN COMMON, or as COMMUNITY PROPERTY:

___________________________                 ___________________________________
Print Name(s)                               Social Security Number(s)

___________________________                 ___________________________________
Signature(s) of Purchaser(s)

___________________________                 ___________________________________
Date                                        Address

If the Purchaser is a PARTNERSHIP, CORPORATION, LIMITED LIABILITY COMPANY or
TRUST:

___________________________                 ___________________________________
Name of Partnership, Corporation            Federal Taxpayer
Limited Liability Company or Trust          Identification Number

___________________________
Date

By:________________________                 ___________________________________
     Name:                                  State of Organization
    Title:
                                            ___________________________________

                                            ___________________________________
                                            Address
SUBSCRIPTION ACCEPTED AND AGREED TO
this __ day of __________, 2006.

SPO MEDICAL  INC.

By:_____________________________
     Name:  Michael Braunold
     Title: CEO

                                       14EXHIBIT 10.2

                FIRST AMENDMENT TO AN SPO SUBSCRIPTION AGREEMENT

         First Amendment to an SPO Subscription Agreement, dated in September
2005 (the "Subscription Agreement"), made as of the 27th day of September 2006
between SPO Medical Inc. (the "Company, or SPO") and the undersigned subscriber
(the "Subscriber") to that Subscription Agreement.

         Whereas, under the Subscription Agreement, SPO sold Subscriber certain
SPO securities (the "Unit"), including (i) a 6% promissory note (the "Note");
and (ii) a common stock purchase warrant (the "Warrant"); and

         Whereas, the parties hereto wish to amend the Subscription Agreement,
the Note and the Warrant in accordance with, and subject to the following terms
and conditions.

NOW THEREFORE, in consideration of the above and the terms and conditions
hereof, the parties, for themselves, their, heirs, successors and assigns agree
as follows:

1.    Unless otherwise defined herein, the capitalized terms used herein shall
have the meanings described in the Subscription Agreement.

2.    The Note

      (i)   Effective the date hereof, the Note shall be due on March 26, 2008
            (the "New Maturity Date"). Unless otherwise provided herein,
            interest accrued thereon shall be paid at the New Maturity Date, or
            upon prepayment of the Note in accordance with Section 3.2 thereof

      (ii)  Effective July 12, 2006, the interest on the Note shall be increased
            from an annual rate of 6% to 8%; and

      (iii) The following new Section 1.1 (a) and (b) shall be added to the
            Note:

      "1.1. (a) At the New Maturity Date, as defined in a First Amendment to the
SPO Subscription Agreement, made as of the 27th day of September 2006, or at the
date Maker prepays all or any portion of the Note, Payee shall have the right,
but not the obligation, to convert all, or any portion of the accrued interest
[the "Converted Accrued Interest (CAI)"] due on this Note to Common Stock at the
conversion price (the "Conversion Price") defined in Section 1.1 (b) below. As
used herein, the "Conversion Date" is the date that Maker receives from Payee
the Notice of Conversion in the form annexed hereto.

<PAGE>
                                       2

      1.1 (b) Within 5 business days of the Maker receiving Payee's Notice of
Conversion, Maker shall issue and deliver to Payee Common Stock representing the
CAI. The number of shares of Common Stock representing the CAI shall be
determined by dividing that amount by the Conversion Price. The Conversion Price
shall be the average closing bid price of the Common Stock on a recognized stock
exchange on which it trades over the ten (10) trading days preceding, but
excluding, the Conversion Date.

3.    The Warrant.

      (i)   Effective the date hereof, the Expiration Date, as defined in the
            Warrant, shall be September 26, 2010;

      (ii)  Effective the date hereof, the Exercise Price of a

      (iii) Warrant shall be $0.60; and

The following new Section 15 shall be added to the Warrant:

            "15. Issuance of Additional Common Stock. If, other than Excepted
            Issuances, as defined below, the Company issues any additional
            Common Stock before the Expiration Date, for a consideration of less
            (a "Lower Consideration Price") than the Exercise Price, at that
            time, and successively thereafter, upon each such issuance, the
            Exercise Price shall be reduced to the Lower Consideration Price. In
            that regard, other than Excepted Issuances, if Company issues any
            debt, warrant, right, and/or option convertible to Common Stock at a
            Lower Consideration Price, upon each such issuance, the Exercise
            Price shall be reduced to the Lower Consideration Price.

Excepted Issuances" means the issuance by Company of Common Stock, or other
securities, or notes duly authorized under its then existing corporate powers in
connection with (i) options grants to purchase Common Stock pursuant to a
Company and shareholder authorized and approved stock option plans and employee
stock purchase plans; (ii) as a result of the exercise of warrants or conversion
of notes which were granted or issued prior to September 27, 2006; and (iii)
warrants, or options issued to consultants in a transaction that an unaffiliated
third party would consider commercially reasonable and fair.

4.    Registration Rights. Section 6 of the Subscription Agreement is deleted in
full, and the following Section 6 inserted in its place and stead:

      "6. Registration Rights. In consideration of the Purchaser's acquisition
      of Units, as described in this Subscription Agreement, the Company will
      register the Common Stock (the "Warrant Stock") underlying the Warrants by
      filing a registration statement not later than April 15, 2007 regarding
      any sale by the Purchaser of the Warrant Stock; provided, however, if the
      Company effects a public offering of its securities, or lists them on a
      recognized stock exchange and the Purchaser is thereby entitled to sell
      the Warrant Stock without a registration statement on such stock exchange,
      and subject to any commercially reasonable lock up agreements requested by
      the Nomad, or an underwriter of Company securities, the Purchaser hereby
      waives any and all registration rights under this Section 6."

<PAGE>
                                       3

5.    With the exception of the above described amendments, the other provisions
of the Subscription Agreement, Note and Warrants shall remain "as is".

6.    The Subscriber hereby waives, releases and forever discharges SPO, its
affiliates and subsidiaries, past and present officers, directors, employees,
agents, attorneys, successors, heirs and their assigns absolutely and
unconditionally from and against any claims, demands, obligations, liabilities,
rights, causes of action and damages, whether liquidated or unliquidated,
absolute or contingent, known or unknown, from the beginning of time to the date
hereof.

IN WITNESS WHEREOF, the parties have executed this First Amendment as of the
date and year first above written.

SPO Medical Inc.                            Subscriber

______________________                      _________________________
Michael Braunold
President & CEO                             Print Name:______________

<PAGE>

                                       4

                              NOTICE OF CONVERSION
                              --------------------

(To be executed by a Payee electing to convert all, of a portion of the Note's
interest to Common Stock)

      The undersigned Payee hereby elects to convert $_________ of accrued
interest on a Note issued by SPO Medical Inc. in September 2005, as amended by a
First Amendment to an SPO Subscription Agreement between SPO and Payee, to
shares of Common Stock, according to the conditions set forth in a SPO
Subscription Agreement to the Note, as amended by the First Amendment.

_______________________________
Payee's Signature

Print Payee's Name:______________________

Print Payee's Address:_________________________

Date:_________________________

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00113-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00113-of-00352.parquet"}]]